Variant report
Variant | nsv962129 |
---|---|
Chromosome Location | chr2:50782384-50785434 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:50783410..50785282-chr2:50787313..50790296,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs189840285 | chr2:50782395-50782396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564409380 | chr2:50782430-50782431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs76161497 | chr2:50782451-50782452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75045341 | chr2:50782483-50782484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568417931 | chr2:50782554-50782555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs61585307 | chr2:50782558-50782559 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs550779979 | chr2:50782593-50782594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs79186182 | chr2:50782596-50782597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11675550 | chr2:50782599-50782600 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs557872526 | chr2:50782609-50782610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs62142291 | chr2:50782666-50782667 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs181411870 | chr2:50782667-50782668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555361306 | chr2:50782694-50782695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs369255249 | chr2:50782721-50782722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574000056 | chr2:50782722-50782723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536403173 | chr2:50782723-50782724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544489351 | chr2:50782773-50782774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556475196 | chr2:50782784-50782785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs115569244 | chr2:50782794-50782795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs373716190 | chr2:50782800-50782801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs13386583 | chr2:50782859-50782860 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs573069171 | chr2:50782888-50782889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs528531637 | chr2:50782889-50782890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185547151 | chr2:50782920-50782921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs62142292 | chr2:50782944-50782945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562030139 | chr2:50782962-50782963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529567047 | chr2:50782991-50782992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs550892309 | chr2:50782992-50782993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs530883921 | chr2:50783005-50783006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs376131203 | chr2:50783183-50783184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369672474 | chr2:50783199-50783200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563028584 | chr2:50783209-50783210 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs61134387 | chr2:50783229-50783230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs78244342 | chr2:50783233-50783234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566568360 | chr2:50783253-50783254 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs78723515 | chr2:50783321-50783322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs533837496 | chr2:50783363-50783364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs549021309 | chr2:50783423-50783424 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544618002 | chr2:50783431-50783432 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567296541 | chr2:50783446-50783447 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529394095 | chr2:50783528-50783529 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs373467652 | chr2:50783555-50783556 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs117064285 | chr2:50783573-50783574 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558387581 | chr2:50783643-50783644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs199504883 | chr2:50783658-50783659 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200020022 | chr2:50783673-50783674 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182942703 | chr2:50783729-50783730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547158271 | chr2:50783736-50783737 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577858137 | chr2:50783756-50783757 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538830848 | chr2:50783771-50783772 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Psychiatric disorder | 19734545 | CNVD |
Autism | 20844286 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Autism | 19218893 | CNVD |
Autism | 22209245 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Schizophrenia | 22118685 | CNVD |
Autism | 20663923 | CNVD |
Schizophrenia | 21285140 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
Schizophrenia | 22885689 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19521646 | CNVD |
Attention deficit hyperactivity disorder | 22214315 | CNVD |
Chronic motor tic disorder | 22214315 | CNVD |
Schizophrenia | 22214315 | CNVD |
Mental retardation | 19896112 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:50766200-50791800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
2 | chr2:50780000-50791400 | Weak transcription | Brain Germinal Matrix | brain |
3 | chr2:50780200-50784000 | Weak transcription | Fetal Heart | heart |
4 | chr2:50783200-50785800 | Enhancers | Hela-S3 | cervix |
5 | chr2:50783800-50785000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr2:50784000-50785200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr2:50784000-50785200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr2:50784000-50785200 | Enhancers | NH-A | brain |
9 | chr2:50784000-50785600 | Enhancers | Fetal Heart | heart |
10 | chr2:50784200-50784400 | Enhancers | HMEC | breast |
11 | chr2:50784200-50784600 | Enhancers | Stomach Mucosa | stomach |
12 | chr2:50784200-50785000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
13 | chr2:50784200-50785400 | Enhancers | NHEK | skin |
14 | chr2:50784400-50785200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
15 | chr2:50784600-50785200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
16 | chr2:50784600-50785400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
17 | chr2:50785000-50785200 | Enhancers | HMEC | breast |
18 | chr2:50785000-50785400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
19 | chr2:50785000-50785800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |